Overbeck, T.R. et al. 2021. Induction therapy with Erlotinib (E) and Gemcitabine/Platinum (GP) in stage III NSCLC. Journal of Pulmonology and Respiratory Research. 5, 1 (Jan. 2021), 001–018. DOI:https://doi.org/10.29328/journal.jprr.1001018.